A new journal for an expanding field

https://doi.org/10.1016/1074-5521(94)90017-5Get rights and content

References (0)

Cited by (3)

  • The chemistry-biology-medicine continuum and the drug discovery and development process in academia

    2014, Chemistry and Biology
    Citation Excerpt :

    At the same time, chemists and biologists in academia began to recognize and appreciate the importance and potential impact of merging their efforts toward the elucidation of biological pathways and disease pathogenesis. This drive toward merging chemistry and biology gave birth to chemical biology (Schreiber and Nicolaou, 1994a, 1994b), an umbrella scientific discipline; one of the main areas of investigation of this domain is the synthesis and use of small organic molecules of natural or designed origins to probe human biology as a means to gain new fundamental knowledge and pave the way for drug discovery and development (Nicolaou, 2013, 2014b; Nicolaou and Montagnon, 2008; Schreiber, 2011; Wetzel et al., 2011). Tools to elucidate biological pathways and lead compounds for drug discovery are two of the most important objectives of organic synthesis and chemical biology today.

  • Aptamers and SELEX in chemistry & biology

    2014, Chemistry and Biology
    Citation Excerpt :

    At present, authors of such papers have the uncomfortable choice of publication in a chemical journal, which is rarely read by biologists, or the reverse. Chemistry & Biology will aim to be accessible to both sets of readers, and we will consider the journal a success if it lowers the language barriers between these two fields, which have so much to say to each other” (Schreiber and Nicolaou, 1994). Now, 20 years later, the journal can definitely be considered a success, as it continues to publish on research topics that are at the intersection of the two fields, and centrally positioned within the scope of chemical biology, a discipline that emerged at about the same time as the journal and has since established itself.

View full text